Summary
The new cardiotonic agent AR-L 115 BS was investigated by means of the double-micro-electrode voltage clamp technique on sheep cardiac Purkinje fibres.
Clinical and pharmacological studies show that AR-L 115 BS increases heart rate as a side effect at medium to high therapeutic doses. The classical analysis of the pacemaker current was therefore performed to study the possible mechanism of this effect at a cellular level. The kinetic parameter s∞ and the reversal potential of the pacemaker current were shifted in the depolarizing direction after exposure to AR-L 115 BS. Peak values of the fully activated pacemaker current were either increased or diminished, while potassium leakage was slightly increased. These results are not related to the action of AR-L 115 BS on beta-adrenergic receptors but possibly due to enhanced intracellular calcium (see third paper in this series). Despite its tendency to increase heart rate, high concentrations of AR-L 115 BS should not be expected to promote arrhythmias in the Purkinje system since the electrophysiological effects tend to counteract each other.
Zusammenfassung
Die neuartige kardiotonisch wirkende Substanz AR-L 115 BS wurde mit Hilfe der ZweiMikroelektroden-voltage-clamp-Technik an Purkinjefäden des Schafherzens untersucht.
Klinische und pharmakologische Voruntersuchungen zeigen, daß AR-L 115 BS die Herzfrequenz erhöht im Sinne einer Nebenwirkung unter mittlere bis hoher therapeutischer Dosierung. Es wurde deshalb der Schrittmacherstrom analysiert, um den Mechanismus dieses Effekts auf zellulärer Ebene zu ermitteln. Der kinetische Parameter s∞ und das Umkehrpotential des Schrittmacherstroms wurden beide in depolarisierender Richtung nach Gabe von AR-L 115 BS verschoben. Maximalwerte des vollaktivierten Schrittmacherstroms wurden entweder erhöht oder erniedrigt; Kaliumleckströme erhöhten sich leicht. Diese Befunde beruhen möglicherweise auf einer Erhöhung intrazellulären Calciums (siehe die 3. Studie dieser Reihe), da eine Beteiligung einer Wirkung von AR-L 115 BS auf β-adrenerge Rezeptoren ausgeschlossen werden konnte. Trotz der Erhöhung der Herzfrequenz sollten hohe Konzentrationen von AR-L 115 BS nicht arrhythmogen auf das Purkinje-System wirken, statt; denn die elektrophysiologischen Wirkungen zeigen eine gegenläufige Tendenz.
Similar content being viewed by others
References
Austel, V., e. Kutter: The theory of sets as a tool in systematic drug design. Arzneim.-Forsch. Drug Res.31, I, 130–135 (1981).
Kutter, E., V. Austel: Application of the theory of sets to drug design/development of a new cardiotonic drug AR-L 115 BS. Arzneim.-Forsch. Drug Res.31, 1, 135–141 (1981).
Schneider, P., M. Bauer, A. Eckenfels, H. Lehmann, L. Lützen, H. Ueberberg: Animal studies on the tolerability of AR-L 115 BS. Arzneim.-Forsch. Drug Res.31, I, 226–232 (1981).
Kikis, D., H. Esser: Erste Erfahrungen mit einer neuen Substanz (AR-L 115 BS) bei der Behandlung der therapierefraktären Herzinsuffizienz. Intensivmedizin18, 22–24 (1981).
Diederen, W., R. Kadatz: Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals. Arzneim.-Forsch. Drug Res.31, I, 146–151 (1981).
Achenbach, C., O. Hauswirth, R. Roskothen, R. Ziskoven: Effects of AR-L 115 BS on the electrophysiological and contractile properties of sheep cardiac fibres. Arzneim.-Forsch. Drug Res.31, I, 171–177 (1981).
Diederen, W., H. Weisenberger: Studies on the mechanism of the positive inotropic action of AR-L 115 BS, a new cardiotonic drug. Arzneim.-Forsch. Drug. Res.31, I, 177–183 (1981).
Trube, G., W. Trautwein: Experiments with AR-L 115 BS on skinned cardiac fibres. Arzneim.-Forsch. Drug Res.31, I, 185–188 (1981).
Herzig, J. W., K. Feile, J. C. Rüegg: Activating effects of AR-L 115 BS on the calcium sensitive force, stiffness and unloaded shortening velocity (Vmax) in isolated contractile structures from mammalian heart muscle. Arzneim.-Forsch. Drug Res.31, I, 188–191 (1981).
Ziskoven, R., C. Achenbach, J. Wiemer, O. Hauswirth: The response of the calcium-dependent myocardial contractility to AR-L 115 BS. Subm. to Basic Res. in Cardiol. (1981).
Achenbach, C., R. Ziskoven, J. Wiemer, O. Hauswirth: The slow inward current isi is decreased by the cardiotonic agent AR-L 115 BS. Subm. to Basic Res. in Cardiol. (1981).
Ferrier, G. F., G. K. Moe: Effect of calcium on acetylstrophanthidin-induced transient depolarizations in canine Purkinje fibres. Circulat. Res.33, 508–515 (1973).
Deck, K. A., R. Kern, W. Trautwein: Voltage clamp technique in mammalian cardiac fibres. Pflügers Arch. ges. Physiol.280, 50–62 (1964).
Noble, D., R. W. Tsien: The kinetics and rectifier properties of the slow potassium current in cardiac Purkinje fibres. J. Physiol.195, 185–214 (1968).
Hauswirth, O., B. N. Singh: Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias. Pharmacol. Reviews30, 5–63 (1979).
McAllister, R. E., D. Noble: The time and voltage dependence of the slow outward current in cardiac Purkinje fibres. J. Physiol.186, 632–662 (1966).
DiFrancesco, D., P. A. McNaughton: The effect of calcium on outward membrane currents in the cardiac Purkinje fibre. J. Physiol.289, 347–373 (1979).
DiFrancesco, D.: Evidence that iK2 in Purkinje fibres is an inward current activating on hyperpolarization. J. Physiol.305, 64–65 P (1980).
DiFrancesco, D.: A study of the ionic nature of the pacemaker current in calf Purkinje fibres. J. Physiol314, 377–393 (1981).
Attwell, D., D. Eisner, I. Cohen: Voltage clamp and tracer flux data: effects of a restricted extra-cellular space. Quart. Rev. Biophys.12, 3, 213–261 (1979).
DiFrancesco, D., M. Ohba, C. Ojeda: Measurement and significance of the reversal potential for the pace-maker current (iK2) in sheep Purkinje fibres. J. Physiol.297, 135–162 (1979).
Chapman, J. B., J. M. Kootsey, E. A. Johnson: A kinetic model for determining the consequences of electrogenic active transport in cardiac muscle. J. theor. Biol.80, 405–424 (1979).
DiFrancesco, D., G. Hart, D. Noble, Y. Shimoni: Voltage-clamp currents at positive potentials in sheep Purkinje fibres: influence of if and K accumulation. J. Physiol. (in press, 1981).
Hashimoto, K., O. Hauswirth, H. D. Wehner, R. Ziskoven: The relation between the current underlying pacemaker activity and beta-adrenoceptor in cardiac Purkinje fibres: A study using adrenaline, procaine, atenolol and penbutolol. Naunyn-Schmiedeberg's Arch. Pharmacol.307, 9–19 (1979).
Achenbach, C., O. Hauswirth, R. Ziskoven: The action of the beta-adrenoceptor antagonist penbutolol on the pacemaker current of cardiac Purkinje fibres. Jap. J. Physiol.31, 537–545 (1981).
Hodgkin, A. L., A. F. Huxley: A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol.117, 500–544 (1952).
Noble, D.: The initiation of the heartbeat. Clarendon Press (Oxford 1975).
Hauswirth, O., D. Noble, R. W. Tsien: Adrenaline: Mechanism of action on the pacemaker potential in cardiac Purkinje fibres. Science162, 916–917 (1968).
DiFrancesco, D., C. Ojeda: Properties of the current if in the sino-atrial node of the rabbit compared with those of the current iK2 in Purkinje fibres. J. Physiol.308, 353–367 (1980).
McAllister, R. E., D. Noble, R. W. Tsien: Reconstruction of the electrical activity of cardiac Purkinje fibres. J. Physiol.251, 1–59 (1975).
Siegelbaum, S. A., R. W. Tsien: Calcium-activated transient outward current in calf cardiac Purkinje fibres. J. Physiol.299, 485–506 (1980).
Kass, R. S., R. W. Tsien: Control of action potential duration by calcium ions in cardiac Purkinje fibres. J. Gen. Physiol.67, 599–617 (1976).
Brown, R. H., D. Noble: Displacement of activation threshold in cardiac muscle by protons and calcium ions. J. Physiol.282, 333–343 (1978).
Bassingthwaighte, J. B., C. H. Fry, J. A. S. McGuigan: Relationship between internal calcium and outward current in mammalian ventricular muscle; a mechanism for the control of the action potential duration? J. Physiol.262, 15–37 (1976).
Isenberg, G.: Is potassium conductance of cardiac Purkinje fibres controlled by [Ca2+]i? Nature253, 273–274 (1975).
Isenberg, G.: Cardiac Purkinje fibres: Resting, action, and pacemaker potential under the influence of [Ca2+] i as modified by intracellular injection techniques. Pflügers Arch.371, 51–59 (1977).
Isenberg, G.: Cardiac Purkinje fibres: The slow inward current component under the influence of modified [Ca2+] i. Pflügers Arch.371, 61–69 (1977).
Isenberg, G.: Cardiac Purkinje fibres: [Ca2+] i controls steady state potassium conductance. Pflügers Arch.371, 71–76 (1977).
Isenberg, G.: Cardiac Purkinje fibres: [Ca2+] i controls the potassium permeability via the conductance components gK1 and\(\bar g_{K2} \). Pflügers Arch.371, 77–85 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ziskoven, R., Achenbach, C., Wiemer, J. et al. A voltage clamp study of the effects of AR-L 115 BS on the pacemaker current of cardiac Purkinje fibres. Basic Res Cardiol 77, 536–551 (1982). https://doi.org/10.1007/BF01907945
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01907945